rogaflatinib (BAY1163877)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rogaflatinib (BAY1163877), covering 2021-12-29 to 2021-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2, Phase 3]